Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells

Authors:

Abstract
The degeneration of nigral (A9) dopaminergic (DA) neurons causes motor symptoms in Parkinson’s disease (PD). We use small-molecule compounds to direct the differentiation of human induced pluripotent stem cells (iPSCs) to A9 DA neurons that share many important properties with their in vivo counterparts. The method generates a large percentage of TH+ neurons that express appropriate A9 markers, such as GIRK2 and ALDH1A1, but mostly not the A10 marker CALBINDIN. Functionally, they exhibit autonomous pacemaking based on L-type voltage-dependent Ca2+ channels and show autoreceptor-dependent regulation of dopamine release. When transplanted in the striatum of 6-OHDA-lesioned athymic rats, the human A9 DA neurons manifest robust survival and axon outgrowth, and ameliorate motor deficits in the rat PD model. The ability to generate patient-specific A9 DA autonomous pacemakers will significantly improve PD research and facilitate the development of disease-modifying therapies.
Funding Information
  • New York State Stem Cell Science (C30290GG)
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS102148, NS113763)
  • U.S. Department of Veterans Affairs (BX003831)
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke

This publication has 59 references indexed in Scilit: